The story of the blue pill offers a complex case study for stakeholders eyeing pharma. While first sales were remarkable, present patent lapse and the rise of alternative versions have severely impacted profitability. https://tessnwil395403.theideasblog.com/41498107/the-blue-pill-and-pharma-a-precarious-bet